Inaugurating a novel adjuvant therapy in urological cancers: Ferroptosis

• Published in: Cancer pathogenesis and therapy Vol. 1; no. 2; pp. 127 - 140
• Main Authors: Xie, Zhaoxiang, Zhou, Qianghua, Qiu, Cheng, Zhu, Dingjun, Li, Kaiwen, Huang, Hai
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2023; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China%Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510120, China%Department of Orthopedic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China%Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong 511518, China; Elsevier
• Subjects: Ferroptosis; GPX4; Lipid; Prostatic cancer; Review; ROS; Urinary system; Ferroptosis; Prostatic cancer; Urinary system; GPX4; Lipid; ROS

Ferroptosis, a distinctive form of programmed cell death, is involved in numerous diseases with specific characteristics, including certain cell morphology, functions, biochemistry, and genetics, that differ from other forms of programmed cell death, such as apoptosis. Many studies have explored fer...